Zepbound® and Ozempic® are two medications commonly prescribed to help manage diabetes. These medications fall into the category of injectable GLP-1 agonist drugs. These are used either alone or in combination with diet and exercise to manage high blood sugar levels in adult patients with type 2 diabetes.
GLP-1 agonists are a type of incretin mimetics, which work by imitating the functions of natural hormones in your body that regulate insulin and blood sugar levels.
Zepbound® and Ozempic® are not insulin medications. They work to lower blood sugar by increasing the secretion of insulin and by slowing down the digestion, so less sugar enters your bloodstream.
These medications are a powerful weapon against diabetes. They not only lower blood sugar levels but also are associated with weight loss and improved cardiovascular health. An added advantage is that they have a relatively low risk of causing low blood sugar (hypoglycemia), especially when not used with other drugs that can trigger such an event.
Understanding the proper use and routine for these medications is of utmost importance. Overdosing or misuse can lead to severe hypoglycemia or other complications. Make sure to follow your doctor’s prescription and routine for these medications.
While both Zepbound® and Ozempic® function similarly, they do differ in specific ways. Patients may find one preferable to the other based on factors such as cost, convenience, and how well each drug controls their blood sugar.
Despite these benefits, these medications should not replace lifestyle modifications required to manage diabetes. A balanced diet, regular exercise, and a healthy lifestyle are necessary for managing diabetes, with these medications serving as an aid.
Like all medications, these drugs have potential side effects. Understanding these will prepare patients fully for their treatment regime, with the ultimate goal being successful management of their condition.
Both Zepbound® and Ozempic® have individual and shared side effects. Some of these side effects are common for all GLP-1 agonists due to their mechanisms of action.
The common side effects for both medications include nausea, vomiting, diarrhea, loss of appetite, and constipation. These usually diminish over time as the body gets adapted to the medication.
Another shared side effect is the potential risk of developing thyroid C-cell tumors. Both Zepbound® and Ozempic® come with this warning. However, it’s important to understand that these are based on studies in rodents, and the relevance to humans is currently unknown.
Zepbound®-specific side effects include pain or skin changes where the injection was given. If severe, these reactions could require medical attention.
Ozempic®, on the other hand, may cause changes in vision and kidney problems. If patients experience extreme thirst, frequent urination, constipation, irregular heartbeat, or muscle weakness while on Ozempic®, they should seek medical help immediately.
Potential cardiovascular effects are another consideration. While Ozempic® shows cardio-protective effects, the cardiovascular effects of Zepbound® are currently unknown.
It’s always important for patients to inform their health care provider about any side effects they experience. Reporting these can potentially help manage and avoid severe consequences.
Learn to Start a Profitable Aesthetics Practice in Just 4-Days!
January 17-20
March 28-31
June 6-9
in sunny Scottsdale, AZ
Start your transitioning to aesthetic medicine and learn everything you need to grow a profitable aesthetics practice in just 4-days!
January 17-20
March 28-31
June 6-9
Scottsdale, AZ
*Members preferred price for 4-day accelerated program. Save $3,605! Membership is only $295/yr and can be added during registration.
The efficacy of both Zepbound® and Ozempic® is primarily evaluated by their ability to reduce A1C levels and promote weight loss in diabetic patients.
In clinical trials, both medications have shown substantial reductions in the A1C level. Ozempic® stands out for consistently delivering A1C reduction of 1.5% to 1.8%, which is considered significant.
Zepbound®, while effective in reducing A1C levels, tends to be slightly less effective than Ozempic® according to clinical trial comparisons. However, patient experiences can vary, and some may see more effective blood sugar control with Zepbound®.
While these markers contribute to a quality understanding of the efficacy of these medications, it is essential to highlight that individual responses to these medications can deviate from clinical trials.
Patients should always consult with their healthcare provider to establish which medication might suit their specific needs and condition best.
Both Zepbound® and Ozempic® are approved for the treatment of type 2 diabetes in adults. These medications work by imitating the functions of the natural hormones in our body that help regulate insulin and blood sugar levels. This makes them effective tools in managing type 2 diabetes, where patients have a resistance to insulin.
However, they are not approved for use in treating type 1 diabetes. People with type 1 diabetes do not produce insulin at all, and these medications cannot replace the function of insulin in the body. Insulin therapy remains the standard treatment for type-1 diabetes.
Regardless of the type of diabetes, these drugs should not be used as the first choice of drugs. They are employed when lifestyle modifications and other first-line therapies don’t provide the desired control of blood sugar.
In patients with a history of diabetic ketoacidosis or pancreatitis, these medications are generally avoided.
Sign up today and expand your knowledge & skills in Botox®, Fillers, Lasers,
Chemical Peels, Microdermabrasion and PRP for Aesthetics!
Both Zepbound® and Ozempic® are injectable GLP-1 agonists. As with other injectable diabetes medications, self-injection may be daunting for some people. But with education and practice, most people find they can administer these medications on their own.
Ozempic® and Zepbound® are administered once a week. The injections are subcutaneously, meaning it’s injected into the fat just beneath the skin. It can be injected at any time, with or without meals.
Injections can be delivered in the stomach area, thigh, or upper arm. The site of the injections should be rotated each time to avoid lumps and skin thickening.
The popularity of a medication can be subjective, often hinging on the individual patient’s experience with the medication. Factors such as efficacy, side effects, administration method, and cost can all play a role in a drug’s popularity.
In a recent head-to-head weight loss study, Zepbound® demonstrated superior efficacy compared to Ozempic®, which could add to its popularity.
Discussions with healthcare providers can help tailor the choice of medication to individual patient needs and circumstances.
Managing diabetes can be challenging, and having a medication that helps control blood sugar levels without causing undesirable side effects can improve the quality of life significantly.
In reducing blood glucose levels, both Zepbound® and Ozempic® help in achieving good glycemic control, which is the primary goal of diabetes treatment. These medications can decrease the risk of hyperglycemia, reducing the symptoms associated with high blood sugar levels, such as frequent urination, increased thirst, and extreme fatigue.
Along with blood sugar control, both Zepbound® and Ozempic® have been observed to facilitate weight loss. As obesity is a common complication in diabetic patients, achieving weight loss can be a significant step toward a healthier life.
It’s also noteworthy that Ozempic® has demonstrated potential to lower the risk of certain cardiovascular events, which is another common complication in people with diabetes.
Overall, these medications offer an effective means of managing diabetes, tackling several conditions associated with it, and providing a more convenient treatment option, adding more healthy and trouble-free days to the patients’ lives.
Even so, remember to consult your healthcare provider to choose the most suitable medication based on your personal needs and medical circumstances.
Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice. For any questions or concerns about your health or medications, please consult your physician or healthcare provider. They are best equipped to provide guidance specific to your medical needs.
Attend the most comprehensive accredited AMA PRA CAT 1 CME Botox® training weekend, learn how to create a profitable practice with the top 5 most lucrative non-invasive treatments, get hands-on Botox® training in a multi-million dollar aesthetics practice and get trained in GLP-1 agonists and other medically-supervised weight loss treatments.
Scottsdale, Arizona
Talk with a program advisor to discuss your hands-on or online training options for Botox®, Aesthetic Medicine and Medical Weight Management (GLP-1 inhibitors, semaglutide, tirzepatide and more).
The IAPAM has been helping physicians, nurse practitioners and physician assistants make more & work less with AMA PRA CAT 1 CME certification & training in Botox®, Aesthetic Medicine and Medical Weight Management since 2006.
Choose from online or hands-on training today!
